Shah Gaurav
Insider CIK 1725922 · RCKT See Remarks, Director · TALS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2026-08-18 | 2026-08-20 | 2,293 | $3.38 | $7.8K | 1,056,594 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2026-08-18 | 2026-08-20 | 2,293 | $3.38 | $7.8K | 1,056,594 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2026-08-13 | 2026-08-17 | 2,837 | $3.38 | $9.6K | 1,058,887 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2026-08-13 | 2026-08-17 | 2,837 | $3.38 | $9.6K | 1,058,887 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise deriv | 2026-05-21 | 2026-05-26 | 76,490 | $1.69 | $129.3K | 0 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise | 2026-05-21 | 2026-05-26 | 76,490 | $1.69 | $129.3K | 1,117,408 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2026-05-21 | 2026-05-26 | 55,684 | $3.09 | $172.1K | 1,061,724 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2026-05-19 | 2026-05-21 | 2,409 | $3.01 | $7.3K | 1,040,918 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2026-05-13 | 2026-05-14 | 2,728 | $3.61 | $9.8K | 1,043,327 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2026-02-18 | 2026-02-20 | 5,990 | $3.34 | $20.0K | 1,046,055 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2026-02-13 | 2026-02-18 | 12,279 | $3.31 | $40.6K | 1,052,045 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2026-02-11 | 2026-02-13 | 870,648 | — | $0 | 870,648 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award | 2026-02-11 | 2026-02-13 | 286,028 | — | $0 | 1,064,324 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2025-11-18 | 2025-11-20 | 6,276 | $2.98 | $18.7K | 778,296 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | F Tax w/h | 2025-08-18 | 2025-08-20 | 2,234 | $3.05 | $6.8K | 784,572 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2025-05-20 | 2025-05-22 | 2,253 | $6.45 | $14.5K | 786,806 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2025-05-16 | 2025-05-20 | 3,621 | $6.53 | $23.6K | 789,059 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | P Buy | 2025-04-10 | 2025-04-14 | 20,000 | $5.08 | $101.6K | 792,680 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2025-02-21 | 2025-02-25 | 16,303 | $10.58 | $172.5K | 772,680 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2025-02-11 | 2025-02-13 | 243,345 | — | $0 | 243,345 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award | 2025-02-11 | 2025-02-13 | 81,655 | — | $0 | 788,983 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2024-11-21 | 2024-11-25 | 11,091 | $13.05 | $144.7K | 707,328 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2024-08-16 | 2024-08-20 | 9,650 | $18.50 | $178.5K | 718,419 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2024-05-16 | 2024-05-20 | 9,790 | $23.35 | $228.6K | 728,069 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise deriv | 2024-05-14 | 2024-05-20 | 7,979 | — | $0 | 23,940 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise deriv | 2024-05-14 | 2024-05-20 | 9,683 | — | $0 | 67,785 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise | 2024-05-14 | 2024-05-20 | 7,979 | — | $0 | 636,451 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise | 2024-05-14 | 2024-05-20 | 9,683 | — | $0 | 646,134 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2024-02-16 | 2024-02-21 | 196,336 | — | $0 | 196,336 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award | 2024-02-16 | 2024-02-21 | 66,577 | — | $0 | 621,339 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2024-02-16 | 2024-02-21 | 20,272 | $29.84 | $604.9K | 554,762 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise deriv | 2024-02-14 | 2024-02-16 | 7,979 | — | $0 | 31,919 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise deriv | 2024-02-14 | 2024-02-16 | 38,849 | — | $0 | 77,468 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise | 2024-02-14 | 2024-02-16 | 46,828 | — | $0 | 575,034 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise deriv | 2023-11-14 | 2023-11-16 | 7,979 | — | $0 | 39,898 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise | 2023-11-14 | 2023-11-16 | 7,979 | — | $0 | 532,833 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2023-08-17 | 2023-08-21 | 4,767 | $15.47 | $73.7K | 524,854 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise deriv | 2023-08-14 | 2023-08-15 | 7,979 | — | $0 | 47,877 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise | 2023-08-14 | 2023-08-15 | 7,979 | — | $0 | 529,621 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | A Award deriv | 2023-06-13 | 2023-06-14 | 20,500 | — | $0 | 20,500 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2023-05-17 | 2023-05-19 | 4,122 | $21.38 | $88.1K | 521,642 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise deriv | 2023-05-14 | 2023-05-16 | 7,979 | — | $0 | 55,856 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise | 2023-05-14 | 2023-05-16 | 7,979 | — | $0 | 525,764 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2023-02-17 | 2023-02-22 | 12,194 | $19.06 | $232.4K | 536,885 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | J Other deriv | 2023-02-14 | 2024-05-20 | 67,785 | — | $0 | 0 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | J Other | 2023-02-14 | 2024-05-20 | 67,785 | — | $0 | 737,859 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2023-02-14 | 2023-02-16 | 116,317 | — | $0 | 116,317 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2023-02-14 | 2023-02-16 | 348,590 | — | $0 | 348,590 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise deriv | 2023-02-14 | 2023-02-22 | 31,440 | — | $0 | 63,835 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2023-02-14 | 2023-02-22 | 116,317 | — | $0 | 116,317 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2023-02-14 | 2023-02-22 | 348,590 | — | $0 | 348,590 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise | 2023-02-14 | 2023-02-22 | 31,440 | — | $0 | 549,079 | SEC↗ |
| TALS Talaris Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-13 | 14,501 | — | $0 | 14,501 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | J Other deriv | 2022-02-14 | 2024-05-20 | 23,940 | — | $0 | 0 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | J Other | 2022-02-14 | 2024-05-20 | 23,940 | — | $0 | 670,074 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2022-02-14 | 2022-02-16 | 297,037 | — | $0 | 297,037 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2022-02-14 | 2022-02-16 | 95,275 | — | $0 | 95,275 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | P Buy | 2022-02-07 | 2022-02-08 | 22,000 | $17.34 | $381.5K | 517,639 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | F Tax w/h | 2021-04-01 | 2021-04-01 | 7,475 | $47.21 | $352.9K | 495,639 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | F Tax w/h | 2021-04-01 | 2021-04-01 | 8,872 | $46.45 | $412.1K | 503,114 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | F Tax w/h | 2021-04-01 | 2021-04-01 | 5,919 | $45.21 | $267.6K | 511,986 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise deriv | 2021-03-31 | 2021-04-01 | 75,880 | — | $0 | 0 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | F Tax w/h | 2021-03-31 | 2021-04-01 | 3,000 | $45.59 | $136.8K | 609,751 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise | 2021-03-31 | 2021-04-01 | 75,880 | $1.69 | $128.2K | 612,751 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | F Tax w/h | 2021-03-31 | 2021-04-01 | 23,003 | $45.06 | $1.04M | 525,398 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | F Tax w/h | 2021-03-31 | 2021-04-01 | 61,350 | $44.24 | $2.71M | 548,401 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | F Tax w/h | 2021-03-31 | 2021-04-01 | 7,493 | $45.94 | $344.2K | 517,905 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | F Tax w/h | 2021-03-30 | 2021-04-01 | 19,984 | $41.80 | $835.3K | 614,092 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | F Tax w/h | 2021-03-30 | 2021-04-01 | 8,505 | $44.34 | $377.1K | 536,871 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | F Tax w/h | 2021-03-30 | 2021-04-01 | 48,732 | $43.86 | $2.14M | 545,376 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | F Tax w/h | 2021-03-30 | 2021-04-01 | 8,667 | $42.80 | $370.9K | 594,108 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2021-02-04 | 2021-02-08 | 185,000 | — | $0 | 185,000 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise deriv | 2020-03-24 | 2020-03-26 | 90,925 | — | $0 | 0 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | F Tax w/h | 2020-03-24 | 2020-03-26 | 32,645 | $13.78 | $449.8K | 1,028,997 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise | 2020-03-24 | 2020-03-26 | 90,925 | $0.43 | $39.1K | 1,061,642 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise deriv | 2020-02-25 | 2020-02-27 | 290,000 | — | $0 | 90,925 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | M Exercise | 2020-02-25 | 2020-02-27 | 290,000 | $0.43 | $124.7K | 976,950 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | F Tax w/h | 2020-02-25 | 2020-02-27 | 6,233 | $20.15 | $125.6K | 970,717 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2020-02-06 | 2020-02-10 | 383,306 | — | $0 | 383,306 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2019-03-05 | 2019-03-05 | 25,000 | $16.90 | $422.5K | 686,950 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2019-03-04 | 2019-03-05 | 24,900 | $17.28 | $430.3K | 711,950 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | S Sale | 2019-03-01 | 2019-03-05 | 25,000 | $17.34 | $433.5K | 736,850 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2019-01-28 | 2019-01-30 | 315,700 | — | $0 | 315,700 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2018-03-29 | 2018-04-02 | 395,000 | — | $0 | 395,000 | SEC↗ |